AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35106618 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright day-Dim evening lighting condition (electric bright light 1250 lx during the day and dim light 5 lx during the evening)
Number of subjects: 14
Study 35106618 — intervention group
Group type: EXPERIMENTAL
Intervention: Dim day-Bright evening lighting condition (dim light during the day and bright light during the evening)
Number of subjects: 14
Study 35106618 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright day-Dim evening lighting condition
Number of subjects: 14
Study 35106618 — intervention group
Group type: EXPERIMENTAL
Intervention: Dim day-Bright evening lighting condition
Number of subjects: 14
Study 35106618 — intervention group
Group type: COMPARATOR
Intervention: Both lighting protocols
Number of subjects: 14
Study 34095981 — intervention group
Group type: EXPERIMENTAL
Intervention: Clockwise non‐invasive explantation
Number of subjects: 31
Study 34095981 — intervention group
Group type: COMPARATOR
Intervention: Counter‐clockwise non‐invasive explantation
Number of subjects: 31
Study 34095981 — intervention group
Group type: EXPERIMENTAL
Intervention: Male patients
Number of subjects: 31
Study 34095981 — intervention group
Group type: COMPARATOR
Intervention: Female patients
Number of subjects: 31
Study 34095981 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall removal torque
Number of subjects: 31
Study 33350051 — intervention group
Group type: EXPERIMENTAL
Intervention: Insoles with a toe-grip bar
Number of subjects: 12
Study 33350051 — intervention group
Group type: COMPARATOR
Intervention: Regular insoles
Number of subjects: 12
Study 36041704 — intervention group
Group type: EXPERIMENTAL
Intervention: tcVNS
Number of subjects: 21
Study 36041704 — intervention group
Group type: COMPARATOR
Intervention: sham
Number of subjects: 21
Study 32062050 — intervention group
Group type: EXPERIMENTAL
Intervention: Swaddling + expressed breast milk
Number of subjects: 33
Study 32062050 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 33
Study 32062050 — intervention group
Group type: EXPERIMENTAL
Intervention: Swaddling
Number of subjects: 33
Study 32062050 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated tucking
Number of subjects: 33
Study 32062050 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressed breast milk
Number of subjects: 33
Study 32062050 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated tucking + expressed breast milk
Number of subjects: 33
Study 35380473 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled Breathing (CB)
Number of subjects: 25
Study 35380473 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted
Number of subjects: 25
Study 34881361 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (100,000 IU as a bolus dose followed by 20,000 IU per week)
Number of subjects: 189
Study 34881361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study 34844774 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-operative thoracostomy tube placement (TP)
Number of subjects: 88
Study 34844774 — intervention group
Group type: COMPARATOR
Intervention: No thoracostomy tube placement (NTP)
Number of subjects: 88
Study 33617367 — intervention group
Group type: EXPERIMENTAL
Intervention: ACCESS intervention (two-semester cognitive-behavioral treatment program)
Number of subjects: 250
Study 33617367 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment condition (control)
Number of subjects: 250
Study 32725848 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital CBT (Daylight)
Number of subjects: 256
Study 32725848 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 256
Study 36163312 — intervention group
Group type: EXPERIMENTAL
Intervention: Restore DCB
Number of subjects: 240
Study 36163312 — intervention group
Group type: COMPARATOR
Intervention: SeQuent® Please DCB
Number of subjects: 240
Study 33640982 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime 400 mg orally
Number of subjects: 15
Study 32798927 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 37
Study 32798927 — intervention group
Group type: COMPARATOR
Intervention: Music Listening (ML)
Number of subjects: 37
Study 34498590 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 0
Study 34498590 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic anticoagulant therapy
Number of subjects: 0
Study 34498590 — intervention group
Group type: EXPERIMENTAL
Intervention: D-dimer levels
Number of subjects: 0
Study 34498590 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulant
Number of subjects: 0
Study 33270762 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous corticosteroids
Number of subjects: 7158
Study 35395697 — intervention group
Group type: EXPERIMENTAL
Intervention: DWP16001 (0.2, 0.5, 1.0, 2.0 or 5.0 mg single dose)
Number of subjects: 12
Study 35395697 — intervention group
Group type: EXPERIMENTAL
Intervention: DWP16001 (0.1, 0.3, 0.5, 1.0 or 2.0 mg once daily for 15 days)
Number of subjects: 12
Study 35395697 — intervention group
Group type: EXPERIMENTAL
Intervention: DWP16001
Number of subjects: 12
Study 35395697 — intervention group
Group type: COMPARATOR
Intervention: Dapagliflozin 10 mg
Number of subjects: 12
Study 35395697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 33865494 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day infusion set replacement
Number of subjects: 2944
Study 33865494 — intervention group
Group type: COMPARATOR
Intervention: 4-day infusion set replacement
Number of subjects: 2944
Study 34409492 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of tranexamic acid (TXA) at incision, three hours post-operatively, and six hours post-operatively
Number of subjects: 99
Study 34409492 — intervention group
Group type: COMPARATOR
Intervention: Single dose of tranexamic acid (TXA)
Number of subjects: 99
Study 34409492 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of tranexamic acid (TXA)
Number of subjects: 99
Study 32335287 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 0
Study 32335287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34260036 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/day of magnesium citrate
Number of subjects: 49
Study 34260036 — intervention group
Group type: COMPARATOR
Intervention: Placebo (one sachet/day)
Number of subjects: 49
Study 33682553 — intervention group
Group type: EXPERIMENTAL
Intervention: WALK-plus
Number of subjects: 40
Study 33682553 — intervention group
Group type: COMPARATOR
Intervention: WALK-regular
Number of subjects: 40
Study 33682553 — intervention group
Group type: EXPERIMENTAL
Intervention: WALK program (both groups)
Number of subjects: 40
Study 32646498 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin
Number of subjects: 340
Study 32646498 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (control)
Number of subjects: 340
Study 33636823 — intervention group
Group type: EXPERIMENTAL
Intervention: G6PD activity cutoff <7.85 U/g hemoglobin (Hb) for males
Number of subjects: 95
Study 33636823 — intervention group
Group type: EXPERIMENTAL
Intervention: G6PD activity cutoff <8.95 U/g Hb for females
Number of subjects: 95
Study 35248257 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolyphysis plus Aerobic Exercise (gEEA)
Number of subjects: 34
Study 35248257 — intervention group
Group type: COMPARATOR
Intervention: Aerobic Exercise group (gEA)
Number of subjects: 34
Study 34053746 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine device
Number of subjects: 0
Study 33725780 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab and Anlotinib
Number of subjects: 1
Study 33725780 — intervention group
Group type: COMPARATOR
Intervention: Durvalumab (maintenance therapy)
Number of subjects: 1
Study 33374147 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin analogue (Capsiate) 24 mg (two doses of 12 mg each)
Number of subjects: 21
Study 33374147 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 21
Study 35852458 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution of 888 mg L-1 GABA
Number of subjects: 11
Study 35852458 — intervention group
Group type: EXPERIMENTAL
Intervention: Pureed fresh tomatoes
Number of subjects: 11
Study 35852458 — intervention group
Group type: COMPARATOR
Intervention: Plain water (control)
Number of subjects: 11
Study 35852458 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution of 3673 mg L-1 glutamate
Number of subjects: 11
Study 33682603 — intervention group
Group type: COMPARATOR
Intervention: Placebo group in RCTs
Number of subjects: 0
Study 33682603 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 vaccines
Number of subjects: 0
Study 36085810 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System (CDSS) model for predicting optimal therapeutic intervention for tinnitus patients
Number of subjects: 0
Study 32299898 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomy support group (ASG)
Number of subjects: 364
Study 32299898 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support group (SSG)
Number of subjects: 364
Study 32299898 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (UCG)
Number of subjects: 364
Study 35992551 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospice nurse mediated aromatherapy for 28 days
Number of subjects: 60
Study 35992551 — intervention group
Group type: COMPARATOR
Intervention: Regular treatment and regular nursing for advanced cancer patients
Number of subjects: 60
Study 34851250 — intervention group
Group type: EXPERIMENTAL
Intervention: Active ultrasound‐guided TAP (US‐TAP)
Number of subjects: 360
Study 34851250 — intervention group
Group type: COMPARATOR
Intervention: Placebo laparoscopic assisted TAP (L‐TAP)
Number of subjects: 360
Study 34851250 — intervention group
Group type: COMPARATOR
Intervention: Placebo US‐TAP
Number of subjects: 360
Study 34851250 — intervention group
Group type: EXPERIMENTAL
Intervention: Active L‐TAP
Number of subjects: 360
Study 35481415 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 50
Study 35481415 — intervention group
Group type: COMPARATOR
Intervention: Routine hospital care (Control Group)
Number of subjects: 50
Study 33415862 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular pressing combined with epidural labor analgesia
Number of subjects: 180
Study 33415862 — intervention group
Group type: COMPARATOR
Intervention: Epidural labor analgesia
Number of subjects: 180
Study 36501071 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation group (RG) - meditation recording during breastfeeding
Number of subjects: 72
Study 36501071 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - no intervention
Number of subjects: 72
Study 32509293 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth-enhanced iCCM supportive supervision and supply chain management
Number of subjects: 3690
Study 32509293 — intervention group
Group type: COMPARATOR
Intervention: iCCM as per current Zambian guidelines (Control)
Number of subjects: 3690
Study 32509293 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth-enhanced iCCM
Number of subjects: 3690
Study 34267301 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceleromyography at the trapezius (group T; n=25)
Number of subjects: 50
Study 34267301 — intervention group
Group type: COMPARATOR
Intervention: Acceleromyography at the adductor pollicis (group A; n=25)
Number of subjects: 50
Study 33534510 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevation Training Mask (ETM) during low-intensity cycling exercise
Number of subjects: 16
Study 33534510 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no ETM) during low-intensity cycling exercise
Number of subjects: 16
Study 32186683 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic transabdominal preperitoneal repair
Number of subjects: 102
Study 32186683 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic transabdominal preperitoneal repair
Number of subjects: 102
Study 36485155 — intervention group
Group type: EXPERIMENTAL
Intervention: stilbesterol
Number of subjects: 0
Study 36485155 — intervention group
Group type: EXPERIMENTAL
Intervention: ephedrine or etilefrine
Number of subjects: 0
Study 36485155 — intervention group
Group type: EXPERIMENTAL
Intervention: sildenafil
Number of subjects: 0
Study 36485155 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 36485155 — intervention group
Group type: EXPERIMENTAL
Intervention: open-label, single-arm intervention
Number of subjects: 0
Study 32826442 — intervention group
Group type: EXPERIMENTAL
Intervention: FCO2 laser (started 3 weeks postoperatively)
Number of subjects: 120
Study 32826442 — intervention group
Group type: EXPERIMENTAL
Intervention: FCO2 laser (started 3 months postoperatively)
Number of subjects: 120
Study 32826442 — intervention group
Group type: COMPARATOR
Intervention: Local creams (control group)
Number of subjects: 120
Study 35353933 — intervention group
Group type: EXPERIMENTAL
Intervention: Watertight multilayer repair
Number of subjects: 21
Study 35353933 — intervention group
Group type: COMPARATOR
Intervention: Non-watertight multilayer repair
Number of subjects: 21
Study 35353933 — intervention group
Group type: EXPERIMENTAL
Intervention: High quality score (≥2/3)
Number of subjects: 21
Study 33208640 — intervention group
Group type: EXPERIMENTAL
Intervention: Stemless implant
Number of subjects: 265
Study 33208640 — intervention group
Group type: COMPARATOR
Intervention: Stemmed implant
Number of subjects: 265
Study 36280812 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive training (IT) group received an additional 8-hour training.
Number of subjects: 21
Study 36280812 — intervention group
Group type: COMPARATOR
Intervention: Standard training (ST) group received standard fellowship education.
Number of subjects: 21
Study 36280812 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ST and IT) showed significant improvement in test scores post-intervention.
Number of subjects: 21
Study 34676616 — intervention group
Group type: EXPERIMENTAL
Intervention: 30Pre - 30 min of resistance exercises (30% of 1RM) before a high carbohydrate meal
Number of subjects: 0
Study 34676616 — intervention group
Group type: EXPERIMENTAL
Intervention: IP - 30 min of resistance exercises (30% of 1RM) immediately following a high carbohydrate meal
Number of subjects: 0
Study 34676616 — intervention group
Group type: EXPERIMENTAL
Intervention: 30Post - 30 min of resistance exercises (30% of 1RM) after a high carbohydrate meal
Number of subjects: 0
Study 34676616 — intervention group
Group type: EXPERIMENTAL
Intervention: 60Post - 30 min of resistance exercises (30% of 1RM) 60 min after a high carbohydrate meal
Number of subjects: 0
Study 34676616 — intervention group
Group type: COMPARATOR
Intervention: C - control, high carbohydrate meal/no exercise
Number of subjects: 0
Study 32560734 — intervention group
Group type: EXPERIMENTAL
Intervention: Dingkun pill (DKP)
Number of subjects: 460
Study 32560734 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 460
Study 34112513 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib added to carboplatin-paclitaxel (6 cycles) and continued as maintenance (30 additional cycles)
Number of subjects: 0
Study 34112513 — intervention group
Group type: COMPARATOR
Intervention: Control arm (carboplatin-paclitaxel only)
Number of subjects: 0
Study 32472628 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 49
Study 32472628 — intervention group
Group type: COMPARATOR
Intervention: Sham-RIC (Control)
Number of subjects: 49
Study 34583694 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-based oral hygiene intervention
Number of subjects: 331
Study 34583694 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention
Number of subjects: 331
Study 34583694 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 331
Study 35039035 — intervention group
Group type: EXPERIMENTAL
Intervention: Recaticimab (75 mg every 4 weeks, 150 mg every 8 weeks, 300 mg every 12 weeks, 150 mg every 4 weeks, 300 mg every 8 weeks, 450 mg every 12 weeks)
Number of subjects: 110
Study 35039035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 33759183 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagined teaching
Number of subjects: 597
Study 33759183 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer teaching
Number of subjects: 597
Study 33759183 — intervention group
Group type: COMPARATOR
Intervention: No teaching
Number of subjects: 597
Study 36054766 — intervention group
Group type: EXPERIMENTAL
Intervention: gshCBT
Number of subjects: 140
Study 36054766 — intervention group
Group type: EXPERIMENTAL
Intervention: gshBWL
Number of subjects: 140
Study 36054766 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 140
Study 34496799 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (48-hour oral treatment)
Number of subjects: 850
Study 34496799 — intervention group
Group type: COMPARATOR
Intervention: Placebo (48-hour oral treatment)
Number of subjects: 850
Study 32963704 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) group
Number of subjects: 57
Study 32963704 — intervention group
Group type: COMPARATOR
Intervention: Control (Con) group
Number of subjects: 57
Study 35240576 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (20 mg·kg body mass‐1)
Number of subjects: 11
Study 35240576 — intervention group
Group type: COMPARATOR
Intervention: Placebo (color-matched)
Number of subjects: 11
Study 32003413 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity plus weight loss (PA+WL; n=21)
Number of subjects: 36
Study 32003413 — intervention group
Group type: COMPARATOR
Intervention: Physical activity plus successful aging health education (PA+SA; n=15)
Number of subjects: 36
Study 35791320 — intervention group
Group type: EXPERIMENTAL
Intervention: CVnCoV vaccine (6 or 12 µg doses)
Number of subjects: 668
Study 35791320 — intervention group
Group type: EXPERIMENTAL
Intervention: CVnCoV vaccine (two doses)
Number of subjects: 668
Study 35791320 — intervention group
Group type: EXPERIMENTAL
Intervention: CVnCoV vaccine (homologous booster doses)
Number of subjects: 668
Study 35791320 — intervention group
Group type: EXPERIMENTAL
Intervention: CVnCoV vaccine
Number of subjects: 668
Study 35791320 — intervention group
Group type: EXPERIMENTAL
Intervention: CVnCoV vaccine (two 12 µg doses)
Number of subjects: 668
Study 33822441 — intervention group
Group type: EXPERIMENTAL
Intervention: Active placebo (0.04 g/kg)
Number of subjects: 231
Study 33822441 — intervention group
Group type: COMPARATOR
Intervention: Non-alcohol control (tonic)
Number of subjects: 231
Study 33822441 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (males: 0.80 g/kg; females: 0.72 g/kg)
Number of subjects: 231
Study 36370066 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 60
Study 36370066 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 33909607 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care‐based integrated mobile health intervention (SINEMA intervention)
Number of subjects: 1299
Study 35552093 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF), 5mg•kg‐1
Number of subjects: 34
Study 35552093 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA), maltodextrin
Number of subjects: 34
Study 35552093 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) for TT genotype
Number of subjects: 34
Study 35552093 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) and DRD2
Number of subjects: 34
Study 36364823 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring-supported intervention (counselling in nutrition and physical activity)
Number of subjects: 302
Study 36364823 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (delayed start of the same intervention)
Number of subjects: 302
Study 32716713 — intervention group
Group type: EXPERIMENTAL
Intervention: Population-based screening for atrial fibrillation
Number of subjects: 0
Study 35260961 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigator intervention
Number of subjects: 1029
Study 35260961 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1029
Study 35943749 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction catheter-guided PLMA insertion (Group SC)
Number of subjects: 160
Study 35943749 — intervention group
Group type: COMPARATOR
Intervention: Standard introducer tool-assisted technique (Group IT)
Number of subjects: 160
Study 34175491 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized clinical trial (RCT)
Number of subjects: 0
Study 34175491 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-world data (RWD)
Number of subjects: 0
Study 34175491 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed statistical framework
Number of subjects: 0
Study 34175491 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted maximum likelihood estimation (TMLE) method
Number of subjects: 0
Study 34175491 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative analysis of RCT and RWD
Number of subjects: 0
Study 34175491 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation results
Number of subjects: 0
Study 32380746 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 g/d goat cheese naturally enriched in n‐3 PUFA and CLA
Number of subjects: 68
Study 32380746 — intervention group
Group type: COMPARATOR
Intervention: 60 g/d control goat cheese
Number of subjects: 68
Study 36057968 — intervention group
Group type: EXPERIMENTAL
Intervention: Quitters (n=50)
Number of subjects: 176
Study 36057968 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewers (n=108)
Number of subjects: 176
Study 32722083 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 enriched meat and eggs
Number of subjects: 28
Study 32722083 — intervention group
Group type: COMPARATOR
Intervention: Normal chicken and eggs
Number of subjects: 28
Study 33604731 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent perception of child anthropometric phenotype (visual silhouette chart ranking from 1 to 7)
Number of subjects: 64
Study 33166989 — intervention group
Group type: EXPERIMENTAL
Intervention: ReACH-based approach
Number of subjects: 49
Study 33166989 — intervention group
Group type: EXPERIMENTAL
Intervention: ReACH principles adherence
Number of subjects: 49
Study 33166989 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with BodPod protocols
Number of subjects: 49